• Nbeal2 2/2 mice are a model of human GPS, characterized by macrothrombocytopenia and a-granule-deficient platelets.
Introduction
As bone marrow megakaryocytes (MKs) develop, they undergo increases in ploidy, nuclear lobulation, and cytoplasmic mass prior to the emergence of the demarcation membrane system. Their development culminates in the formation of proplatelets, microtubulecontaining cell extensions 1, 2 that protrude through the vascular endothelium and are released into the bloodstream as nascent platelets. 3 Mature platelets contain abundant stores of secretory vesicles that include dense (d-) granules, lysosomes, and a-granules (50-80 per platelet), which carry endogenously synthesized or endocytosed cargo 4, 5 and arise from budding vesicles in the MK trans-Golgi network that mature into multivesicular bodies and nascent a-granules 5, 6 that are transported into proplatelets. 7 Insights into platelet granule formation and function have come from investigating patients and mutant mice with secretory granule deficiencies. Studies of conditions associated with a lack of d-granules-Hermansky-Pudlak syndrome and Chediak-Higashi syndrome (MIM214500)-have implicated several vesicular trafficking molecules in d-granule formation. [8] [9] [10] [11] Studies of arthrogryposis, renal dysfunction, and cholestasis syndrome, in which platelets lack a-granules, have shown 2 proteins to be required for a-granule development: VPS33B and its binding partner VPS16B. 12, 13 Recently, we and others have identified loss of function mutation of NBEAL2 (neurobeachin-like 2) as the cause of gray platelet syndrome (GPS; MIM139090), an autosomal recessive bleeding disorder characterized by macrothrombocytopenia and gray-appearing platelets with decreased/absent a-granules [14] [15] [16] [17] [18] and a-granule proteins. 19, 20 Patients with GPS have moderate bleeding symptoms, splenomegaly, and progressive bone marrow fibrosis characterized by abnormal reticulin deposition in the bone marrow. 16, 19 Although studies using mouse models of d-granule deficiency have shown the importance of platelet d-granule secretion during in vivo thrombus formation, 21 the importance of isolated a-granule secretion has not been investigated because of lack of an appropriate model. Here we report the results of studies using the The online version of this article contains a data supplement.
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counts, and a profound deficiency of platelet a-granules and their soluble cargo proteins. Expression of the a-granule membrane protein P-selectin was decreased in Nbeal2 2/2 platelets, but it was observed to mobilize to the surface of activated cells. Nbeal2
2/2
platelets showed decreased response to agonists in vitro, whereas in vivo assays showed increased bleeding in Nbeal2 2/2 mice and impaired platelet thrombus formation in response to laser-induced arterial injury. These results confirm the importance of a-granule secretion for platelet function. Studies of bone marrow and cultured MKs also revealed significant abnormalities in Nbeal2
mice, providing the first indication that impaired a-granule formation due to the absence of NBEAL2 can have major consequences for MK development and platelet production.
Methods Animals

Nbeal2
2/2 mice were generated from cryopreserved spermatozoa obtained from the Mutant Mouse Regional Resource Center at the University of California, Davis, from strain B6;129S5-Nbeal2 tm1Lex /Mmucd, in which exons 4 to 11 from the 54-exon Nbeal2 gene were deleted by homologous recombination. Spermatozoa were used for in vitro fertilization of WT C57BL/6J mouse oocytes to generate embryos that were transferred into pseudopregnant C57BL/6J females by the Toronto Centre for Phenogenomics (TCP) to generate heterozygous litters, which were crossed to generate homozygous Nbeal2 2/2 mice. Sequencing of the targeted deletion region (exons 4-11 of Nbeal2) of ear punch samples was done via polymerase chain reaction using 1 59 primer (59-GTCCTGCTTGACCTACCGTC-39) and 2 39 primers (59-CAGGGAGGATAACGAGATAGTCTT-39 and 59-CCTAG GAATGCTCGTCAAGA-39). Two polymerase chain reaction reactions with the same 59 primer and 1 of each 39 primer results in predicted 223 bp 1 no product for WT and no product 1 401 bp for the homozygous deletion, respectively. These confirmed Nbeal2
, or Nbeal2 2/2 status.
Age-and sex-matched WT mice were C57BL/6J, obtained from the TCP. This study was approved by the TCP Animal Use Protocols (AUP #0215-H).
Platelet enumeration, bone marrow and spleen analysis, bright field and electron microscopy, immunoblotting, platelet preparations for immunofluorescence microscopy, megakaryocyte culture, immunostaining, high-resolution confocal laser immunofluorescence microscopy, in vitro assessments of platelet function, tail bleeding assay, intravital analysis of platelet accumulation, and activation after laserinduced injury to cremaster muscle arterioles There was no increased reticulin staining in Nbeal2 2/2 spleens. Bone marrow morphology assessed by hematoxylin/eosin and reticulin staining was indistinguishable from WT (supplemental Figure 1) , confirming the absence of myelofibrosis.
Platelet number and morphology
Automated blood analysis showed mean platelet counts for Nbeal2 /L, SD 55, n 5 3), whereas mean platelet volume was greater (Nbeal2 2/2 6.69 fL, SD 0.35, n 5 3, vs WT:
5.10 fL, SD 0.85, n 5 3). On blood films platelets from WT ( Figure 1A ) and Nbeal2 1/2 , heterozygous mice ( Figure 1B) show typical punctate staining, whereas Nbeal2 2/2 platelets appear pale ( Figure 1C ). These observations are consistent with GPS. Platelet ultrastructure was examined via thin-section transmission electron microscopy (TEM), in which Nbeal2 2/2 a-granule deficiency was clearly evident (Figure 1D -E; supplemental Figure 2A 
Platelet proteins
Platelet lysates were examined for protein content via immunoblot analysis; equivalent sample loading was achieved by loading lysates from similar numbers of platelets, measuring total protein concentrations and probing for actin or glyceraldehyde-3-phosphate dehydrogenase. We observed (Figure 2 ) that the MK-synthesized a-granule cargo proteins VWF, platelet factor 4, and thrombospondin-1 were greatly reduced or absent in Nbeal2 2/2 platelet lysates (Figure 2A -C).
Normal levels of endothelium-derived VWF were present in Nbeal2 2/2 mouse plasma ( Figure 2E ). Reduced amounts of plasma-derived fibrinogen were present in Nbeal2 2/2 platelets, whereas plasma levels were normal ( Figure 2D,F) . The a-granule membrane protein P-selectin is present at approximately 48% of WT levels ( Figure 2G ; 48.4, SD 5.3, n 5 3 determinations), indicating that despite lacking mature granules and their soluble cargo, Nbeal2 2/2 platelets appear to contain the membrane constituents of a-granules. This contrasts with the effects of loss-of-function MK-derived thrombospondin-1 (TSP1; A), platelet factor 4 (PF4; B), and von Willebrand factor (VWF; C) were undetectable or significantly reduced in Nbeal2 2/2 in comparison with WT platelet lysates, and plasma VWF (E) and fibrinogen (F) levels were normal. (D) Plasma-derived fibrinogen (Fgn) was present in decreased amounts in Nbeal2 2/2 platelets. (G) P-selectin in Nbeal2 2/2 platelets was present at approximately 48% of WT levels. VPS33B (H) and VPS16B (I) were present at similar levels in WT and Nbeal2 2/2 platelets. Lysate from equivalent numbers of platelets was loaded in each lane, and protein loading is indicated by probing for actin or glyceraldehyde-3-phosphate dehydrogenase (GAPDH). See the "Methods" section for antibody details.
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12,13 VPS33B and VPS16B are both present in approximately equivalent amounts in Nbeal2 2/2 and WT platelets ( Figure 2H -I), suggesting that NBEAL2 affects a later stage of a-granule biogenesis than do these proteins. The intracellular distribution of platelet proteins was examined via high-resolution immunofluorescence confocal microscopy. Staining for a-granule cargo proteins was negative in Nbeal2 : 3.21 mm, SD 0.57, n 5 50 platelets; P , .01, Mann-Whitney 2-tailed test). The distribution of P-selectin within resting Nbeal2 2/2 platelets appeared less well defined than in WT cells ( Figure 3A -B, middle panels), and both showed similar patterns of shape change and surface mobilization of P-selectin after thrombin activation ( In a tail transection assay ( Figure 4H ), Nbeal2 2/2 mice showed increased rate of blood loss in comparison with WT and a 5-fold higher cumulative blood loss after 40 minutes (Nbeal2 2/2 322 6 125 mL vs WT 71 6 30 mL, n 5 11 for both, P 5 .03, unpaired t test). These results point to a hemostatic deficiency in Nbeal2 2/2 mice.
Platelet function in vivo
Platelet accumulation in laser-injured cremaster arterioles was assessed using established methods. Platelet accumulation in thrombi (measured by Dylight-tagged anti-GPIbb, X488), expressed as sum of accumulation 3 minutes after injury and maximal accumulation, was lower in Nbeal2 mice had similar time to half-maximal activation ratio of CD41 and of P-selectin ( Figure 4K -L). However, further inspection of the P-selectin activation reveals the maximal anti-P-selectin to antiGPIbb ratio is lower in Nbeal2 2/2 mice than in WT mice ( Figure 4M ).
Thus, although platelet accumulation in thrombi that form at sites of laser injury in Nbeal2 2/2 mice is impaired, the rate of activation of the platelets within the thrombi is not different from that in WT. The amount of P-selectin that Nbeal2 2/2 platelets can express in thrombi appears to be limited. These results show that the platelet activation time in thrombi is not altered in Nbeal2 2/2 mice, but their maximal P-selectin expression is impaired.
Abnormalities in megakaryocyte structure and development
The a-granule deficiency observed in platelets was also noted in bone marrow MKs from Nbeal2 2/2 mice analyzed by TEM ( Figure 5 ). Figure 6H ). In addition, we observed that although the proportion of MK-lineage cells present in 5-day WT cultures was 14.0% 60.62, consistent with other reports, 24 the proportion present in Nbeal2 2/2 cultures was significantly lower at 7.67% 60.12 (P , .01, 2-tailed t test; n 5 3 cultures and 900 cells for each). This indicates that Nbeal2 2/2 MKs may be overall less viable than are WT. Developmental differences between WT and Nbeal2 2/2 MKs were explored in detail by examining expression of VWF, a large protein normally packaged in distinct regions of a-granules. 25 We observed that although VWF is present in early Nbeal2 2/2 and WT MKs, by the mature stages there is a marked difference in intracellular VWF distribution ( Figure 7 ; supplemental Figure 3A -B).
In permeabilized WT MKs, VWF is distributed throughout the nascent platelet territories delineated by CD41 ( Figure 7A ), and in Nbeal2 2/2 MKs, VWF is concentrated at the cell periphery ( Figure 7B ). This pattern of VWF distribution was confirmed by examining unpermeabilized MKs ( Figure 7C ), where the absence of VWF staining in WT cells is contrasted by the strong colocalization of VWF and CD41 at the outer membrane of mature Nbeal2 2/2 MKs. In some cases we also saw evidence that VWF may accumulate in inclusions or be released from Nbeal2 2/2 cells.
The abnormal presence of VWF outside of Nbeal2 2/2 MKs was also observed via TEM of pre-embed immunogold labeled sections ( Figure 7D ).
Discussion
As with human heterozygous carriers of GPS-associated NBEAL2 mutations, we observed no obvious differences between WT and TEM examination confirmed the virtual absence of a-granules (Figure 1 ; supplemental Figure 2A ). On average, 4.8 a-granules are seen in WT mouse platelet thin sections; this is slightly less than the 5.5 reported for human platelets, 12 which may reflect the relatively smaller size of mouse platelets. 26 These observations confirm that as with human NBEAL2, 15, 17, 18 the absence of functional NBEAL2 protein in mice results in macrothrombocytopenia with platelets that are profoundly a-granule deficient. In contrast to their a-granule deficiency, Nbeal2 2/2 mouse platelets had normal lysosome constituents (LAMP1; supplemental Figure 2B -C). However, Nbeal2 2/2 mouse platelets had fewer dense granules per whole-mount electron microscopy than WT and lower ATP secretion in response to both thrombin (Nbeal2 2/2 /WT 5 0.83) and U46619 (Nbeal2 2/2 /WT 5 0.41). By comparison, human GPS platelets contain normal to increased dense granules as measured by whole-mount electron microscopy. 27 Splenomegaly is observed in GPS patients 16, 19 and was also evident in 4-month-old Nbeal2 2/2 mice, in which the average spleen weight was 1.83 that of WT, containing increased numbers of MKs, suggesting augmented extramedullary megakaryopoiesis. Another feature of GPS is the prevalence of myelofibrosis in the bone marrow, indicated by increased reticulin staining. 16, 19 We did not detect differences in reticulin staining between Nbeal2 2/2 and WT mice in either the bone marrow (supplemental Figure 1) or spleen; however, myelofibrosis progresses with age in GPS, 16 and it may be that 4-month-old mice are not old enough for this condition to become evident. We will continue to monitor our Nbeal2 2/2 mice as they age. As in GPS, the absence of a-granules in Nbeal2 2/2 platelets is expected to be accompanied by a lack of cargo proteins. Immunoblot analysis of platelet lysates failed to detect the megakaryocytesynthesized soluble cargo proteins platelet factor 4, thrombospondin-1, and VWF (Figure 2A-C) , whereas plasma-derived fibrinogen was greatly reduced ( Figure 2D ). VWF and fibrinogen were present at normal levels in Nbeal2 2/2 plasma ( Figure 2E-F) . These cargo protein deficiencies have also been observed in GPS. 16, 19 The membrane-spanning a-granule protein P-selectin was present in Nbeal2 2/2 platelets, albeit at approximately half of the normal amount ( Figure 2G ), and granule membranes and membraneassociated proteins such as P-selectin have been observed in GPS platelets by us 15 and others. 16, 19, 20, 25, [28] [29] [30] [31] The presence of P-selectin in platelets from Nbeal2 2/2 mice and GPS patients suggests that despite the lack of cargo, some of the membrane constituents and vesicular precursors of a-granules may be present. This contrasts with the situation in arthrogryposis, renal dysfunction, and cholestasis syndrome, where loss of function of VPS33B or VPS16B leads to platelets lacking P-selectin 12, 13 and presumably a-granule precursors. Loss of VPS16B expression results in decreased levels of VPS33B, suggesting that these proteins interact during a-granule biogenesis. 13 We examined their possible interaction with NBEAL2 by assessing levels of VPS33B and VPS16B in Nbeal2 2/2 platelets ( Figure 2H-I) , which proved to be the same as WT. Because loss of NBEAL2 function appears to have no effect on VPS33B and VPS16B, we reason that these proteins and their human homologs likely act independently of NBEAL2 and are involved in an earlier stage of a-granule formation.
Nbeal2 encodes a polypeptide of 2754 amino acids containing multiple domains 15, 17, 18 (supplemental Figure 4) , which as with other BEACH domain-containing proteins, has been implicated in cellular vesicular trafficking. 15, [32] [33] [34] [35] High-resolution confocal immunofluorescence microscopy 15 revealed that although P-selectin is present in the central region of both WT and Nbeal2 2/2 platelets, the latter show a less orderly and more diffuse P-selectin distribution ( Figure 3B ) in relation to the tightly packed loops visible in WT platelets (which presumably correlate with mature a-granules). These differences, however, do not prevent P-selectin from being externalized when Nbeal2 2/2 platelets are activated with thrombin ( Figures 3D and 4C ,L,M), although at lower amounts, as has also been observed in GPS platelets. 28 This may relate to the decreased total levels of P-selectin in Nbeal2 2/2 platelets and abnormal intracellular distribution, possibly indicating altered precursor a-granule structures that cannot fuse as effectively with the plasma membrane as normal a-granules do in activated platelets. Optical aggregometry revealed a decreased response of washed Nbeal2 2/2 platelets to CRP, thrombin, and the thromboxane analog U46619 (Figure 4D-F) . Unlike WT, Nbeal2 2/2 platelets did not aggregate in the presence of 0.05 U/mL thrombin; weak aggregation was seen when exogenous fibrinogen was added. This indicates that lack of a-granule-borne fibrinogen may partially account for the relatively weak aggregation of Nbeal2 2/2 platelets.
Because flow cytometry showed decreased thrombin and ADPinduced a IIb b 3 activation ( Figure 4A-B) , and impedance aggregometry showed a decreased collagen response ( Figure 4G ), impaired platelet activation independent of a-granule-borne fibrinogen is also evident. Taken together, these results show that Nbeal2 2/2 platelets have a lowered response in relation to WT to agonist-mediated activation. For comparison, in vitro platelet aggregation studies summarized by the Nurden group 19 and Gunay-Aygun et al 16 show that decreased responses to varying agonists-including collagen, thrombin, and ADP-have been observed in many GPS patients. Several proteins secreted from platelet a-granules, including VWF and coagulation factor V, are known to be important for platelet hemostatic function at sites of blood vessel injury, where an absence of a-granules in GPS platelets is thought to contribute to a bleeding phenotype that is characteristically mild to moderate. 16, 36, 37 The results of tail bleeding assays ( Figure 4H ) clearly show increased blood loss in Nbeal2 2/2 mice in comparison with WT, suggesting that their platelets do not function normally in vivo. Increased bleeding of BLOOD, 7 NOVEMBER 2013 x VOLUME 122, NUMBER 19 MOUSE MODEL OF GRAY PLATELET SYNDROME 3355
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2/2 mice is not due to abnormalities in endothelial cell-derived VWF, because plasma levels are normal ( Figure 2E ). Nor are their decreased platelet counts likely to be the cause because reductions up to 97.5% have been shown to have little influence on bleeding in mice. 38 The in vivo function of Nbeal2 2/2 mouse platelets was directly examined using high-speed confocal immunofluorescence microscopy to monitor response to laser-induced damage in cremaster muscle arterioles. We observed that Nbeal2 2/2 mice show relatively decreased platelet accumulation at injury sites ( Figure 4I-J) , whereas their rate of platelet activation within the thrombi is not significantly different from WT ( Figure 4K-L) . The future availability of an appropriate antibody will allow testing the possibility that absent NBEAL2 in the vasculature contributes to the decreased platelet accumulation at injury sites. Splenectomy increases platelet counts in GPS patients, 16 and a shortened mean platelet half-life has been described using 111 In labeling, 19 suggesting that splenic sequestration and increased platelet destruction are causes of GPS-associated thrombocytopenia. Because this thrombocytopenia is noted to be progressive with age and accompanied by myelofibrosis, 16 the more severe thrombocytopenia seen in older GPS patients likely indicates that fibrotic bone marrow is a poor environment for MK maturation and platelet production. The overall bone marrow morphology of our 4-monthold Nbeal2 2/2 mice was normal (supplemental Figure 1) , indicating that their thrombocytopenia may be related to abnormal MK development. The presence of ultrastructural abnormalities in Nbeal2
MKs was confirmed by transmission electron microscopy using direct fixation of bone marrow cells ( Figure 5 ). Nbeal2 2/2 MKs revealed a marked reduction of a-granules and platelet territories, which is likely associated with abnormalities in the demarcation membrane system (Figure 5B,D) . Vesicles within Nbeal2 2/2 MKs appeared empty with a vacuolated appearance (compare Figure 5C WT with Figure 5D Nbeal2 2/2 ). Ultrastructural examination of GPS MKs has also revealed highly vacuolated cells with decreased a-granules. 19 A striking feature noted in Nbeal2 2/2 MKs was the frequent observation of emperipolesis (the presence of an intact cell within the cytoplasm of another cell); for example, Figure 5E shows 3 cells within the same MK, and an Nbeal2 2/2 MK containing a nucleated cell is also shown in Figure 7B (496 diamidino-2-phenylindole 1 merge panel). MK emperipolesis has also been observed in GPS, 31 MYH9-related disease, 39 thrombocytosis, myelofibrosis, and other conditions. 39 Although the mechanism is unclear, the involvement of aberrant P-selectin expression has been proposed to mediate emperipolesis. Figure 3A -B). We evaluated their development by classifying populations of cells (n = 600) into visually distinguishable stages: early, mature, extending, spread, and proplatelet MKs (Figures 6A-E) . The resulting population distributions ( Figure 6G ) show that in relation to WT, a significantly larger proportion of Nbeal2 2/2 MKs were in the early stage and fewer were in the mature, extending, and proplatelet stages, indicating a developmental delay in Nbeal2 2/2 MKs. In addition, the proportion of spread MKs was significantly higher in the Nbeal2 Figure 6H ). Several mechanisms can be proposed to account for abnormal Nbeal2 2/2 MK development. One possibility is that in addition to being important for a-granule formation, NBEAL2 may also be involved in the development of other membrane compartments such as the demarcation membrane, because Nbeal2 2/2 MKs appear to be more vacuolated than are WT ( Figure 5D ). Another possibility is that NBEAL2 is involved in formation of the cytoskeletal organization of MKs, proplatelets, and platelets, which influences platelet size and production. 40 Platelets from GPS patients are larger and rounder than normal 15, 20, 40 and contain thicker peripheral microtubule coils. 40, 41 NBEAL2 contains multiple domains (supplemental Figure 4) , which may interact with components of the MK and platelet cytoskeleton in unknown ways. Atypical Nbeal2 2/2 MK development could also be associated with abnormal intracellular protein distribution arising from the failure to incorporate cargo proteins into maturing a-granules, as we observed with VWF ( Figure 7 ). In mature WT MKs, VWF is dispersed throughout the cytoplasm ( Figure 7A ), whereas in mature Nbeal2 2/2 MKs, VWF protein is concentrated at the periphery ( Figure 7B ), and in some cells was observed in concentrated structures that sometimes extended beyond the outer membrane delineated by CD41 labeling ( Figure 7C ) and is observed outside of native (not cultured) Nbeal2 2/2 MKs labeled with immunogold ( Figure 7D ). VWF forms multimeric complexes that are organized into highly structured tubules that are stored in either a-granules in MKs or Weibel-Palade bodies in endothelial cells in an acidic environment. 42, 43 mouse MKs in culture and noted abnormalities that indicate that GPS-associated thrombocytopenia likely arises from delayed and aberrant platelet development that may be directly linked to the failure of MKs to form mature a-granules and properly package their cargo.
